Ohio Adm.Code 4729:2 | Ohio Administrative Code 4729:2 — State Board of Pharmacy | Pharmacy Interns

Chapter 4729:2-1 Definitions

Ohio Adm.Code 4729:2-1-01 Definitions - pharmacy interns.

As used in this division:

(A) "Abandoned application" means an application for a licensure pursuant to this division where the applicant fails to complete all application requirements within thirty days after being notified by the board. An applicant forfeits all fees associated with an abandoned application. The board shall not be required to act on any abandoned application and the application may be destroyed by board staff. If the application is abandoned, the applicant shall be required to reapply for licensure, submit the required fee and comply with the licensure requirements in effect at the time of reapplication.

(B) "Addicted to or abusing alcohol or drugs" means the chronic and habitual use of alcohol or the use of a drug of abuse as defined in section 3719.011 of the Revised Code by an individual to the extent that the individual no longer can control the individual's use of alcohol or drugs, the individual is physically or psychologically dependent on alcohol or drugs, or the individual's use or abuse of alcohol or drugs endangers the health, safety, or welfare of the individual or others.

(C) "Board of pharmacy" or "board" means the state board of pharmacy established under Chapter 4729. of the Revised Code.

(D) "Business day" means any day other than Saturday, Sunday or a holiday recognized by the state of Ohio on which the offices of the board of pharmacy are not open for business.

(E) "Compounding" has the same meaning as defined in section 4729.01 of the Revised Code and agency 4729 of the Administrative Code.

(F) "Controlled substance" has the same meaning as in section 3719.01 of the Revised Code.

(G) "Disciplinary action," unless otherwise stated in this division, means any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction, regardless of whether the action occurred by formal proceeding, consent, settlement, or other agreement:

(1) An action to revoke, suspend, restrict, limit, or refuse to grant or renew a license, registration, or certification;

(2) A summary or emergency suspension of a license, registration or certification, of any length, and any subsequent revision to the action;

(3) An administrative fine or money penalty, taken as a result of a formal proceeding, to include any fine or money penalty connected to the delivery of health care services or taken in conjunction with other adverse licensure, registration, or certification actions, such as revocation, suspension, censure, reprimand, or probation;

(4) An action to reprimand or place the license, registration, or certification holder on probation;

(5) The issuance of a corrective action plan only if such issuance is in conjunction with other adverse licensure, registration or certification actions, such as revocation, suspension, reprimand, probation, or surrender;

(6) The withdrawal of a renewal application for licensure, registration or certification while under investigation;

(7) The non-renewal of a license, registration, or certification while under investigation or to avoid an investigation;

(8) The surrender or other relinquishment of a license, registration or certification in lieu of a formal sanction against a person's license, registration, or certificate, whether permanent or temporary;

(9) In lieu of an adverse licensure, registration, or certification action, a licensing agency issues a consent order in which a person agrees not to re-apply for a license, registration, or certification in the future;

(10) An enforceable agreement not to practice or to be placed into inactive or other equivalent status while under investigation or in exchange for not conducting an investigation.

(H) "Dispense" means the final association of a drug with a patient pursuant to a prescription, drug order, or other lawful order of a prescriber and the professional judgment of and the responsibility for interpreting, preparing, compounding, labeling, and packaging a specific drug.

(I) "In good standing" means a preceptor to which all the following apply:

(1) Has not been denied the privilege of supervising interns by the board;

(2) Has not been denied a license, registration, or certificate by any public agency or licensing agency;

(3) Does not have a license, registration, or certificate limited, suspended, or revoked by any public agency or licensing agency.

(J) "Personal supervision" or "direct supervision" means a pharmacist shall be physically present in the pharmacy, or in the area where the practice of pharmacy is occurring, to provide personal review and approval of all professional activities. The pharmacist providing personal supervision of an intern shall comply with the following:

(1) Be readily available to answer questions of the pharmacy intern.

(2) Make appropriate in-process and end-process verifications of the activities of the pharmacy intern.

(3) Be fully responsible for the practice of the pharmacy intern.

(4) Except as provided in paragraph (J)(5) of this rule, the number of interns engaged in the practice of pharmacy at any time is limited to not more than two for each pharmacist on duty, unless otherwise approved by the board's executive director or the director's designee.

(5) The number of pharmacy interns engaged in the administration of immunizations at any time is limited to not more than six for each pharmacist providing personal supervision.

(K) "Pharmacist" means an individual who holds a valid pharmacist license in accordance with Chapter 4729. of the Revised Code.

(L) "Place on probation" means to take action against a license, for a period of time determined by the board, which imposes conditions or other requirements, or suspends or otherwise restricts some or all of the activities in which the licensee may engage.

(M) "Preceptor" means an individual responsible for seeing that a pharmacy intern is properly supervised and exposed to all aspects of an internship program.

(1) A preceptor shall be either:

(a) A pharmacist who holds a license to practice pharmacy that is in good standing. Unless employed by a school of pharmacy, a preceptor shall have at least one year of practice experience as a licensed pharmacist.

(b) A person who is of good moral character and is qualified to direct the practical experience in the area approved by the board's executive director or the director's designee pursuant to rule 4729:2-2-05 of the Administrative Code.

(2) A person may serve as the preceptor for more than one intern.

(3) A preceptor must report to the board on the progress and aptitude of an intern when requested by the board's executive director or the director's designee.

(N)

(1) "Positive identification" means a method of identifying a person that does not rely solely on the use of a private personal identifier such as a password, but must use a secure means of identification that includes any of the following:

(a) A manual signature on a hard copy record;

(b) A magnetic card reader;

(d) A biometric method;

(e) A proximity badge reader;

(f) A board approved system of randomly generated personal questions;

(g) A printout of every transaction that is verified and manually signed within a reasonable period of time by the individual who performed the action requiring positive identification. The printout must be maintained for three years and made readily retrievable; or

(h) Other effective methods for identifying individuals that have been approved by the board.

(2) A method relying on a magnetic card reader, a bar code reader, a proximity badge reader, or randomly generated questions for identification must also include a private personal identifier, such as a password, for entry into a secure mechanical or electronic system.

(O) "Practical experience affidavit" is a form provided by the state board of pharmacy used to submit evidence of practical experience for internship credit pursuant to rule 4729:2-2-06 of the Administrative Code.

(P) "Practice of pharmacy" has the same meaning as in division (B) of section 4729.01 of the Revised Code.

(Q) "Readily retrievable" means that records maintained in accordance with this division shall be kept in such a manner that, upon request, they can be produced for review no later than three business days to an agent, officer, or inspector of the board.

(R) "Responsible person" has the same meaning as defined in rule 4729:5-2-01 of the Administrative Code.

(S) "Refuse to grant or renew" means to deny original or continued licensure for a period of at least twenty-four months. After twenty-four months, or such period of time as the individual board order may require, a person licensed by the board or a person seeking to attain such status by licensure, and whose license the state board of pharmacy has refused to grant or renew, may make application to the board for issuance of a new license. A person that seeks to attain such status by licensure, whose license the state board of pharmacy has refused to grant or renew, must meet all requirements established by the board in rule and as may be set forth in the person's board order.

(T) "Revoke" means to take action against a license rendering such license void and such license shall not be reissued. Revoke is an action that is permanent against the licensee.

(U) "School of pharmacy" has the same meaning as a college of pharmacy or a department of pharmacy of a university, which has been recognized and approved by the state board of pharmacy in accordance with rule 4729-5-01 of the Administrative Code.

(V) "State" means a state of the United States, the District of Columbia, the Commonwealth of Puerto Rico or a territory or insular possession subject to the jurisdiction of the United States.

(W) "Suspend" means to take action against a license rendering such license without force and effect for a period of time as determined by the state board of pharmacy. The board may require that an individual whose license or registration has been suspended may not be employed by or work in a facility licensed by the state board of pharmacy to possess or distribute dangerous drugs during such period of suspension.

(X) "Summary suspension" means to take immediate action against a license without a prior hearing rendering such license without force and effect for a period of time as indicated in section 3719.121 of the Revised Code. The board may suspend a license issued pursuant to Chapter 4729. of the Revised Code by utilizing a telephone conference call to review the allegations and take a vote.

(Y) "Veteran" means anyone who is serving or has served under honorable conditions in any component of the armed forces, including the national guard and reserve.

Last updated May 19, 2025 at 7:59 AM

History

Effective: May 19, 2025
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-05

(A) The pharmacy internship credit requirement for the licensure examinations shall be deemed satisfactorily completed when the intern has either:

(1) Successfully graduated after December 31, 2006 with a doctor of pharmacy degree ("Pharm.D.") from a school of pharmacy approved by the "Accreditation Council for Pharmacy Education" (A.C.P.E.) and the state board of pharmacy; or

(2) Obtained a total of at least one thousand seven hundred and forty hours of documented supervised practical experience accepted by the state board of pharmacy which may include any hours:

(a) Documented on a practical experience affidavit pursuant to rule 4729:2-2-06 of the Administrative Code; or

(b) Worked in another state where the appropriate licensing agency submits to the board an official verification of the actual practical experience contact hours completed that meets the requirements in paragraph (A)(2) of this rule.

(B) No internship credit shall be granted by the board for practical experience until a foreign pharmacy graduate has established educational equivalency by obtaining a "Foreign Pharmacy Graduate Examination Commission" (FPGEC) certificate, and has established proficiency in spoken English by successfully completing the "Test of English as a Foreign Language, Internet-based test (TOEFL iBT)" pursuant to rule 4729:2-2-07 of the Administrative Code.

(C) Practical experience obtained pursuant to paragraph (A)(2)(a) of this rule may include up to five hundred hours of internship credit at a site other than a pharmacy licensed as a terminal distributor of dangerous drugs (e.g., manufacturing, research, consulting, drug information, and drug utilization review). To receive credit for such experience, a formal request must be submitted to the executive director or the director's designee for approval prior to beginning the experience in these areas. The request shall include a detailed description of the internship with respect to time, place, duties, responsibilities, professional supervision, and the person supervising the experience. The request must be signed by both the intern and the person supervising the experience and returned with a completed statement of preceptor form. If approved by the board, the hours must be documented using a practical experience affidavit pursuant to rule 4729:2-2-06 of the Administrative Code.

(D) Internship credit may be denied for the practical experience accumulated when an intern is found in violation of section 4729.16 of the Revised Code or agency 4729 of the Administrative Code.

Last updated July 1, 2024 at 5:18 PM

History

Effective: July 1, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-06

(A) At the beginning of internship, or if there is a change in preceptor or employment site, the intern must submit a completed statement of preceptor form within thirty days of the change to the state board of pharmacy. The filing of a statement of preceptor form is not required for a change of preceptor or internship site related to a school of pharmacy academic program.

(B) The intern is responsible for submitting the following required forms to certify the hour and supervision requirements pursuant to rule 4729:2-2-05 of the Administrative Code:

(1) A statement of preceptor form must be received by the state board of pharmacy for each pharmacy intern within thirty days of beginning an internship under a preceptor's supervision.

(a) No credit will be given for practical experience obtained prior to thirty days of the date that the statement of preceptor form is received by the board office; except, in the event of extraordinary circumstances and when due to no fault of the intern, the board may accept a retroactive date of filing for the statement of preceptor.

(b) The intern must file a statement of preceptor form whenever the intern changes internship sites and/or preceptors. The form must be submitted within thirty days of a change of internship site and/or preceptor.

(2) A practical experience affidavit form shall be used to submit evidence of practical experience for internship credit earned outside of the intern's school of pharmacy academic program.

(a) Practical experience reported on the affidavit shall be the total number of actual clock hours worked during the reported time period rounded to the nearest hour. The hours reported must be able to be documented by payroll or other records which may be examined by the state board of pharmacy upon request.

(b) Practical experience affidavits must be signed by the preceptor and submitted to the state board of pharmacy. In the event of the unavailability of the preceptor's signature due to extraordinary circumstances and due to no fault of the intern, the board may accept an alternative method for verification of a practical experience affidavit.

(c) Practical experience affidavits for a calendar year may be submitted at any time, except that they must be submitted to the board no later than one year after the credit is earned.

(d) No internship credit shall be granted by the board for practical experience obtained before licensure as an intern or during a period when the intern's license has lapsed.

Last updated March 7, 2024 at 3:43 PM

History

Effective: March 7, 2024
Promulgated Under: 119.03

Chapter 4729:2-2 Licenses

Ohio Adm.Code 4729:2-2-01 Licensure as a pharmacy intern.

(A) A license as a pharmacy intern shall only be issued for the purpose of allowing those individuals who intend to become licensed pharmacists the opportunity to obtain the practical experience required for examination and licensure as a pharmacist.

(B) If a person is actively working towards the requirements for licensure as a pharmacist and seeks to work as a pharmacy intern in Ohio, the person shall:

(1) Comply with at least one of the following:

(a) Have successfully completed at least sixty semester or ninety quarter hours of college, be enrolled in a school of pharmacy, and has begun taking professional classes directly related to the practice of pharmacy;

(b) Have obtained a first professional degree in pharmacy from a program which has been recognized and approved by the state board of pharmacy; or

(c) Have established educational equivalency by obtaining a "Foreign Pharmacy Graduate Examination Commission (FPGEC)" certificate and have established proficiency in spoken English by successfully completing the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) pursuant to rule 4729:2-2-06 of the Administrative Code.

(2) Submit electronic fingerprint or ink impressions for a criminal records check pursuant to section 4729.071 of the Revised Code.

(3) Apply to the state board of pharmacy for licensure as a pharmacy intern.

Last updated March 7, 2024 at 3:43 PM

History

Effective: March 7, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-06

(B) The intern is responsible for submitting the following required forms to certify the hour and supervision requirements pursuant to rule 4729:2-2-05 of the Administrative Code:

(1) A statement of preceptor form must be received by the state board of pharmacy for each pharmacy intern within thirty days of beginning an internship under a preceptor's supervision.

(2) A practical experience affidavit form shall be used to submit evidence of practical experience for internship credit earned outside of the intern's school of pharmacy academic program.

(c) Practical experience affidavits for a calendar year may be submitted at any time, except that they must be submitted to the board no later than one year after the credit is earned.

(d) No internship credit shall be granted by the board for practical experience obtained before licensure as an intern or during a period when the intern's license has lapsed.

Last updated March 7, 2024 at 3:43 PM

History

Effective: March 7, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-02 Application for licensure as a pharmacy intern.

(A) Each person seeking a license as a pharmacy intern for the purpose of obtaining the practical experience required for examination and licensure as a pharmacist shall submit the following to the state board of pharmacy:

(1) A completed application form as provided by the board, which can be accessed by visiting http://www.pharmacy.ohio.gov.

(2) Required fee.

(3) Documentation, in a manner determined by the board, that the applicant has successfully completed a minimum of sixty semester or ninety quarter hours of college work.

(4)

(a) Documentation, in a manner determined by the board, from a school of pharmacy that has been recognized and approved by the board certifying that the person is currently enrolled in a school of pharmacy and has begun taking professional classes directly related to the practice of pharmacy; or

(b) Either of the following:

(i) Certification provided by the national association of boards of pharmacy documenting the applicant has obtained a first professional degree in pharmacy from a program that has been recognized and approved by the state board of pharmacy; or

(ii) Certification of having established educational equivalency by obtaining a "Foreign Pharmacy Graduate Examination Commission (FPGEC)" certificate, and evidence of successful completion of the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) pursuant to rule 4729:2-2-06 of the Administrative Code.

(5) Any other information or documentation as determined by the board.

(B) The state board of pharmacy may license an applicant as a pharmacy intern as soon as the state board of pharmacy receives all the required items set forth in paragraph (A) of this rule and the results of a criminal records check pursuant to section 4729.071 of the Revised Code.

(D) A pharmacy intern licensed in another state may apply for licensure by reciprocity by complying with the requirements listed in this rule.

(E) Pursuant to division (B)(2) of section 4796.03 of the Revised Code, the board hereby waives the requirements set forth in division (B)(1) of section 4796.03 of the Revised Code.

(F) In accordance with section 4729.15 of the Revised Code, the required fee for licensure as a pharmacy intern shall be thirty dollars and any transaction fee as required by section 125.18 of the Revised Code.

(G) Pursuant to section 4729.16 of the Revised Code, a limited or restricted license may be issued to an applicant upon the determination of the board.

Last updated March 7, 2024 at 3:43 PM

History

Effective: March 7, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-03 Criminal records check for pharmacy interns.

(A) Pursuant to section 4729.071 of the Revised Code, an applicant seeking an initial license as a pharmacy intern must first submit fingerprint impressions to the Ohio bureau of criminal identification and investigation (BCI&I) for a criminal records check.

(B) Pursuant to section 4776.02 of the Revised Code, the criminal records check performed by BCI&I shall consist of both a BCI&I criminal records check and a federal bureau of investigation (FBI) criminal records check. BCI&I shall send the results of the BCI&I and FBI criminal records checks directly to the state board of pharmacy.

(1) Be based on electronic fingerprint impressions that are submitted directly to BCI&I from a WebCheck provider agency or ink impressions. The state board of pharmacy may accept the results of a criminal records check based on ink impressions only in the following circumstances:

(a) Readable electronic fingerprint impressions cannot be obtained or are rejected by either BCI&I or FBI;

(b) The applicant is from out-of-state;

(2) Results will only be considered valid if the fingerprint impressions were obtained within one year of the date the application is received by the board.

Last updated January 3, 2024 at 12:18 PM

History

Effective: March 1, 2018
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-04 Pharmacy intern license renewal and expiration.

(A) Except as provided in paragraph (B) of this rule, a pharmacy intern license issued by the state board of pharmacy in accordance with Chapter 4729. of the Revised Code entitles the individual to whom it is issued to practice as a pharmacy intern until the next renewal date.

(B) An initial pharmacy intern license issued by the state board of pharmacy on or after the first of May of every odd-numbered year in accordance with Chapter 4729. of the Revised Code entitles the individual to whom it is issued to practice as a pharmacy intern until the renewal date immediately following the next required renewal date.

(D) An individual who fails to renew their license by the fifteenth day of September of every odd-numbered year shall not engage in the practice of pharmacy until a valid license is issued by the board.

(E) A pharmacy intern shall submit the renewal fee as specified in section 4729.15 of the Revised Code, including any transaction fee as required by section 125.18 of the Revised Code.

(F) A pharmacy intern may renew their license each year provided they are actively working toward the requirements for licensure as a pharmacist and otherwise meet the requirements and rules of the state board of pharmacy. The state board of pharmacy may refuse to grant or renew license to practice pharmacy as an intern.

(G) An intern shall be considered to be actively working towards licensure as a pharmacist if the intern has complied with all of the statutes and rules regarding internship since licensure as a pharmacy intern, and:

(1) The intern is currently enrolled in a school of pharmacy and is taking professional classes directly related to the practice of pharmacy; or

(2) The intern is a member of the armed forces and can provide evidence that the intern has been accepted for enrollment in a school of pharmacy upon their release from the armed forces.

(H) An intern who has obtained a first professional degree in pharmacy from a school of pharmacy, or who has established equivalency by obtaining a "Foreign Pharmacy Graduate Examination Commission" (FPGEC) certificate, may renew the intern's license only once. In the event of extraordinary circumstances and when due to no fault of the intern, the board may approve additional renewals or license extensions.

(I) Upon receiving an initial license to practice as a pharmacist, the intern's license to practice as a pharmacy intern terminates.

(J) A pharmacy intern, other than a graduate pharmacist intern, must notify the state board of pharmacy and the intern's current employer and any subsequent employer where practicing as a pharmacy intern within three business days if the intern is no longer enrolled in a school of pharmacy. Upon notification that an intern is no longer enrolled in a school of pharmacy, the board shall inactivate the intern license and the intern shall no longer be permitted to practice as a pharmacy intern in this state.

Last updated March 7, 2024 at 3:43 PM

History

Effective: March 7, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-05 Internship credit.

(A) The pharmacy internship credit requirement for the licensure examinations shall be deemed satisfactorily completed when the intern has either:

(2) Obtained a total of at least one thousand seven hundred and forty hours of documented supervised practical experience accepted by the state board of pharmacy which may include any hours:

(a) Documented on a practical experience affidavit pursuant to rule 4729:2-2-06 of the Administrative Code; or

(D) Internship credit may be denied for the practical experience accumulated when an intern is found in violation of section 4729.16 of the Revised Code or agency 4729 of the Administrative Code.

Last updated July 1, 2024 at 5:18 PM

History

Effective: July 1, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-07

Successful completion of the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) shall be the following minimum scores or higher:

(A) Writing: twenty-four;

(B) Speaking: twenty-six;

(D) Reading: twenty-two.

Last updated March 4, 2026 at 1:32 PM

History

Effective: September 15, 2017
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-08 Pharmacy intern change of name, address or employment.

(A) A pharmacy intern, who has a legal change of name, shall notify the board of pharmacy, in a manner determined by the board, within thirty days from the effective date of such change. Such notification of a name change shall be accompanied by one of the following:

(1) A notarized affidavit;

(2) A certified copy of a court record;

(3) A certified copy of a marriage certificate;

(4) A government-issued identification card which reflects the pharmacist's name change; or

(5) Any other documentation as approved by the board.

(B) Requests for a duplicate wall certificate shall be issued in the intern's new name and shall be accompanied by the following:

(1) The wall certificate issued in the original name; and

(2) The required fee of twenty-two dollars and fifty cents.

(C) Upon receipt of the required documents and fee in paragraphs (A) and (B) of this rule, the board will forward the duplicate wall certificate issued in the intern's new name.

(D) A pharmacy intern who changes their mailing or email address shall notify the board of pharmacy, in a manner determined by the board, of the new address within thirty days after the effective date of such change.

(E) A pharmacy intern who changes their place of employment shall notify the board of pharmacy, in a manner determined by the board, of the address of the principal place where they practice within thirty days after they have commenced such practice.

Last updated March 7, 2024 at 3:43 PM

History

Effective: March 7, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-10 Veteran and military family provisions related to pharmacy intern licensure.

(A) Renewal of an expired license.

(1) In accordance with section 5903.10 of the Revised Code, a holder of an expired license shall be granted a renewal of the license by the state board of pharmacy at the usual cost without penalty if not otherwise disqualified because of mental or physical disability and if either of the following applies:

(a) The license was not renewed because of the holder's service in the armed forces.

(b) The license was not renewed because the holder's spouse served in the armed forces of the United States or a reserve component of the armed forces and the service resulted in the holder's absence from this state.

(2) A pharmacy intern shall submit proper documentation certifying the active duty service and length of active duty service. Documentation required to obtain a renewal pursuant to paragraph (A)(1) of this rule will be published on the state board of pharmacy's website: www.pharmacy.ohio.gov.

(B) The state board of pharmacy may implement fee waivers for licensure. If implemented, fee waivers will be published on the state board of pharmacy's web site: www.pharmacy.ohio.gov.

Last updated January 3, 2024 at 12:18 PM

History

Effective: March 1, 2018
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-2-11 Expedited pharmacy intern licensure for members of the military and spouses who are licensed in another jurisdiction.

(A) As used in this rule:

(1) "Military duty" has the same meaning as in section 4743.041 of the Revised Code.

(2) "In good standing" means an applicant to which both the following apply:

(a) Has not been denied a license, registration, or certificate by any public agency or licensing agency; and

(b) Does not have a license, registration, or certificate limited, suspended, or revoked by any public agency or licensing agency.

(B) To meet the requirements set forth in section 4743.041 of the Revised Code, the state board of pharmacy shall issue an expedited license to a pharmacy intern applicant if the individual or the individual's spouse is on military duty in this state and the applicant complies with all the following:

(1) The individual holds a valid license or other authorization to practice as a pharmacy intern issued by any other state or jurisdiction.

(2) The individual shall be in good standing in the state or jurisdiction of licensure.

(3) The individual complies with application requirements set forth in rule 4729:2-2-01 of the Administrative Code.

(4) The individual presents adequate proof to the board, in accordance with paragraph (G) of this rule, that the individual or the individual's spouse is on military duty in this state.

(5) The individual complies with sections 4776.01 to 4776.04 of the Revised Code. An applicant shall submit fingerprint impressions for a criminal records check in accordance with rule 4729:2-2-03 of the Administrative Code.

(C) The board shall, within twenty-four hours after receiving the report under division (A) of section 4776.04 of the Revised Code, notify an individual applying for an expedited license in accordance with this rule that the board has received the results of a criminal records check.

(D) The board shall issue an expedited pharmacy intern license under this rule, provided that the applicant meets the requirements of this rule, within fourteen days of having received the results of a criminal records check. The board shall not be required to issue an expedited license if any of the following apply:

(1) The applicant fails to meet the application requirements set forth in this rule or section 4743.041 of the Revised Code.

(2) The applicant is under investigation by the licensing agency of any other state or jurisdiction.

(3) The applicant is in violation of any provision section 4729.16 of the Revised Code or rules adopted thereunder.

(E) Notwithstanding any other provision of the Revised Code or Administrative Code, the board shall waive or refund all fees associated with the issuance of an initial expedited license issued under this rule. Additional fee waivers or refunds shall be granted in accordance with other provisions of the Revised Code, Administrative Code, and board resolution.

(F) All licenses issued pursuant to this rule shall comply with the licensure renewal requirements set forth in Chapter 4729:2-2 of the Administrative Code.

(G) Pursuant to section 5903.04 of the Revised Code:

(1) A pharmacy intern shall submit proper documentation necessary to determine if the applicant is a service member or veteran, or the spouse or surviving spouse of a service member or veteran. Documentation requirements shall be published on the state board of pharmacy's website: www.pharmacy.ohio.gov.

(2) The board's executive director or the director's designee shall design a process to record, track, and monitor applications that have been received from a service member, veteran, or the spouse or surviving spouse of a service member or veteran.

(3) The board's executive director or the director's designee shall design a process to prioritize and expedite certification or licensing for each applicant who is a service member, veteran, or the spouse or a surviving spouse of a service member or veteran.

Last updated May 15, 2026 at 7:31 AM

History

Effective: May 15, 2026
Promulgated Under: 119.03

Chapter 4729:2-3 Pharmacy Intern Practices

Ohio Adm.Code 4729:2-3-01 Practice as a pharmacy intern.

In addition to assisting a pharmacist with technical functions, a pharmacy intern may perform the following professional functions under the direct supervision of a pharmacist:

(A) The sale of schedule V controlled substances pursuant to agency 4729 of the Administrative Code.

(B) The receipt of oral prescriptions pursuant to rule 4729:5-5-10 of the Administrative Code and other applicable provisions of agency 4729 of the Administrative Code.

(C) The transfer and receipt of a non-controlled prescription copy pursuant to rule 4729:5-5-11 of the Administrative Code and other applicable provisions of agency 4729 of the Administrative Code.

(D) The act of patient counseling pursuant to rule 4729:5-5-09 of the Administrative Code and other applicable provisions of agency 4729 of the Administrative Code.

(E) The administration of immunizations pursuant to section 4729.41 of the Revised Code and agency 4729 of the Administrative Code.

(F) The documentation of informed consent to administer an immunization pursuant to section 4729.41 of the Revised Code.

(G) The dispensing of overdose reversal drug pursuant to section 3715.502 of the Revised Code and other dangerous drugs as authorized under Chapter 4729. of the Revised Code.

(H) Non-sterile compounding.

(I) Sterile compounding.

(J) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.

(K) Contacting a prescriber or prescriber's agent to obtain clarification for a prescription order if the clarification does not require the exercise of professional judgment.

(L) Performing diagnostic laboratory testing pursuant to agency 4729 of the Administrative Code.

(M) Requesting refill authorizations for dangerous drugs from a prescriber or the prescriber's agent.

(N) Notwithstanding the definition of direct supervision, a pharmacy intern may stock an automated drug dispensing unit and floor stock at a location licensed as a terminal distributor of dangerous drugs if a pharmacist is not physically present at the licensed location and all of the following apply:

(1) A pharmacist is readily available to answer questions of the intern;

(2) A pharmacist is responsible for conducting routine verifications of the activities of the intern to prevent the diversion of dangerous drugs;

(3) A pharmacist is fully responsible for all activities conducted by the intern at the licensed location.

Last updated July 1, 2024 at 5:18 PM

History

Effective: July 1, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:5-5-10

(A) A prescription, to be valid, must be issued for a legitimate medical purpose by an individual prescriber acting in the usual course of the prescriber's professional practice. The responsibility for the proper prescribing is upon the prescriber, but a corresponding responsibility rests with the pharmacist who dispenses the prescription. An order purporting to be a prescription issued not in the usual course of bona fide treatment of a patient is not a prescription and the person knowingly dispensing such a purported prescription, as well as the person issuing it, shall be subject to the penalties of law.

(B) A pharmacist dispensing an outpatient prescription shall comply with the requirements of this chapter, including, but not limited to, the following:

(1) Ensure that patient information is profiled pursuant to rule 4729:5-5-07 of the Administrative Code;

(2) Perform prospective drug utilization review pursuant to rule 4729:5-5-08 of the Administrative Code; and

(3) Ensure that the drug is labeled pursuant to rule 4729:5-5-06 of the Administrative Code.

(1) The front of hard copy prescriptions for controlled substance dangerous drugs shall be clearly notated to indicate receipt by the pharmacy in a manner that does not destroy any of the original information contained on the prescription but prevents the unauthorized duplication of the prescription.

(2) When a pharmacist dispenses a drug pursuant to an original prescription, the pharmacist must record the date of such dispensing and the pharmacist's positive identification.

(3) When a pharmacist dispenses a drug pursuant to an authorized refill of a prescription, the pharmacist must record the date of such dispensing and the pharmacist's positive identification.

(D) Oral prescriptions:

(1) A pharmacist shall make a record of the full name of the prescriber and, if transmitted by the prescriber's agent, the full name of the agent. The pharmacist is responsible for ensuring the validity of the source of the oral prescription.

(2) Upon receiving a prescription from a recording device or voice mail service, a pharmacist shall transcribe the information. The pharmacist must document on the original prescription the full name of the prescriber and, if transmitted by the prescriber's agent, the full name of the agent. The pharmacist is responsible for ensuring the validity of the prescription removed from the recording device or voice mail service.

(3) A licensed pharmacy intern may receive telephone prescriptions and remove prescriptions from a recording device or voice mail service if the pharmacist on duty who is personally supervising the activity of the intern determines that the intern is competent to perform this function.

(a) The intern shall immediately transcribe the prescription, document the full name of the prescriber and, if transmitted by the prescriber's agent, the full name of the agent and shall review the prescription with the pharmacist on duty. Prior to dispensing, positive identification of the intern and the pharmacist on duty shall be recorded to identify the responsibility for the receipt of the oral order.

(b) The pharmacist on duty is responsible for the accuracy of the prescription.

(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription with the prescriber or the prescriber's agent.

(4) A certified pharmacy technician may receive telephone prescriptions and remove prescriptions from a recording device or voice mail service for non-controlled drugs in accordance with rule 4729:3-3-04 of the Administrative Code.

(E) Facsimile prescriptions:

A facsimile shall only be valid as a prescription if a pharmacy retains a printed copy of a facsimile prescription or an electronic copy of the facsimile prescription in accordance with rule 4729:5-5-03 of the Administrative Code. The facsimile prescription shall comply with the requirements of rule 4729:5-3-11 of the Administrative Code.

(F) Electronic prescriptions:

(1) A pharmacy receiving electronic prescriptions directly into its computer system shall ensure original prescription information received from the prescriber is maintained in accordance with rule 4729:5-5-03 of the Administrative Code.

(2) A pharmacy computer system receiving electronic prescriptions shall:

(a) Comply with the applicable provisions of 21 C.F.R. 1311 (05/01/19); and

(b) Have the capability to receive an ICD-10-CM medical diagnosis code for all controlled substance prescriptions pursuant to rule 4729:5-5-15 of the Administrative Code.

(G) Except as provided for in section 4729.46 of the Revised Code, a pharmacist shall not dispense a dangerous drug for the first time beyond six months from the date of issuance of a prescription.

(H) The quantity prescribed shall be considered the quantity dispensed, unless the quantity dispensed meets any of the following:

(1) If the dispensed prescription is less than the quantity prescribed, the pharmacist shall note the quantity dispensed on the original prescription or within a computerized recordkeeping system.

(2) If the quantity dispensed on a prescription is greater than the quantity prescribed, the pharmacist shall record on the original prescription or within a computerized recordkeeping system the name of the authorizing prescriber, the full name of the agent of the prescriber, if applicable, the quantity authorized to be dispensed, and the date that the authorization was obtained.

(3) A prescription dispensed in accordance with section 4729.40 of the Revised Code. The pharmacist shall note the quantity dispensed on the original prescription or within a computerized recordkeeping system.

(I) Where a prescription is written using a generic name, or where the pharmacist dispenses an equivalent drug product pursuant to the provisions of sections 4729.38 and 4729.381 of the Revised Code, the brand name or drug name and name of the manufacturer or distributor of the drug or the national drug code (NDC) number of the drug dispensed must be recorded in the record of dispensing by the pharmacist.

(J)

(1) A prescription issued by a prescriber who experiences a change of status, as defined in paragraph (J)(2) of this rule, that precludes a continued prescriber-patient relationship may be dispensed by a pharmacist in accordance with the following:

(a) In the exercise of the pharmacist's professional judgment:

(i) The drug is essential to sustain the life of the patient or continue therapy for a chronic condition of the patient; or

(ii) Failure to dispense the drug to the patient could result in harm to the health of the patient.

(b) The prescription was issued prior to the prescriber's change of status, as defined in paragraph (J)(2) of this rule, and in accordance with all applicable provisions of state and federal laws, rules and regulations.

(c) For a non-controlled substance prescription, a pharmacist may dispense up to a thirty-day supply as provided in the prescription or, if the standard unit of dispensing for the drug exceeds a thirty-day supply, the amount of the drug dispensed shall not exceed the standard unit of dispensing. The pharmacist shall exercise professional judgment in determining the amount of the drug to be dispensed.

(d) For a controlled substance prescription, a pharmacist may dispense up to a seventy-two-hour supply as provided in the prescription. The pharmacist shall exercise professional judgment in determining the amount of the drug to be dispensed.

(2) A change of status includes, but is not limited to, the following: death, incapacity, suspension, surrender or revocation of the prescriber's license or registration, or permanent relocation.

(3) A prescription for a dangerous drug dispensed in accordance with paragraph (J)(1) of this rule is considered void after the initial dispensing and may not be dispensed again. Following the initial dispensing of the drug, a pharmacist shall utilize a manual or electronic method for invalidating the prescription to prevent further dispensing.

Last updated May 19, 2026 at 4:58 PM

History

Effective: December 1, 2020
Promulgated Under: 119.03

Ohio Adm.Code 4729:5-5-11

(A) An outpatient pharmacy may send or receive copies of prescriptions in accordance with the following:

(1) Copies of prescriptions shall be transferred only between pharmacists, except as follows:

(a) Pharmacy interns in accordance with paragraph (G) of this rule; and

(b) Certified pharmacy technicians in accordance with rule 4729:3-3-04 of the Administrative Code.

(2) Copies of prescriptions for controlled substances shall be communicated directly between two pharmacists and, except as provided in paragraph (A)(3) of this rule, shall be transferred only one time.

(3) Pharmacies electronically sharing a real time, online database may transfer a controlled substance prescription up to the maximum number of refills permitted by law and the prescriber's authorization.

(4) The copy transferred shall be an exact duplicate of the original prescription, except that it shall also include the following:

(a) Serial prescription number assigned to the prescription;

(b) Name, address and, if a controlled substance prescription, the drug enforcement administration (D.E.A.) registration number of the pharmacy transferring the copy;

(d) Date of last refill;

(e) Number of valid refills or quantity remaining; and

(f) The full name of the transferring pharmacist or, if transferred by a pharmacy intern or certified pharmacy technician, the full name of the transferring pharmacy intern or certified pharmacy technician and the pharmacist on duty who is supervising the activity of the intern or technician.

(5) A pharmacist transferring a copy of a controlled substance prescription shall:

(a) Write the word "VOID" on the face of the invalidated prescription in a manner that does not destroy any of the original information contained on the prescription; for electronic prescriptions, information that the prescription has been transferred must be added to the prescription record.

(b) Record on the reverse of the invalidated prescription the name, address, and the D.E.A. registration number of the pharmacy to which it was transferred and the first and last name of the pharmacist receiving the prescription information; for electronic prescriptions, such information must be added to the prescription record.

(d) Ensure copies of controlled substance prescriptions may only be transferred if the prescription record in the system is invalidated to prevent further dispensing at the original pharmacy.

(6) A pharmacist, pharmacy intern, or certified pharmacy technician transferring a copy of a non-controlled substance prescription shall:

(a) Utilize a manual or electronic method for invalidating the prescription to prevent further dispensing at the original pharmacy.

(b) Record the name and address of the pharmacy to which it was transferred.

(c) If transferred orally, the first and last name of the pharmacist or authorized pharmacy personnel receiving the prescription information.

(d) Record the date of the transfer and the name of the pharmacist, pharmacy intern, or certified pharmacy technician transferring the information.

(7) A pharmacist, pharmacy intern, or certified pharmacy technician receiving a copy of a prescription must comply with the following:

(a) Exercise reasonable diligence to determine the validity of the copy.

(b) Transcribe an oral prescription by recording all the information transferred. The oral prescription shall include all information required in paragraph (A)(4) of this rule and the pharmacist, pharmacy intern, or certified pharmacy technician shall write the word "transfer" on the face of the prescription or indicate the prescription was transferred within a computerized record keeping system.

(d) Prior to dispensing, positive identification of the receiving pharmacist shall be recorded to identify who is responsible for the receipt of the copy. For pharmacy interns, positive identification shall be documented in accordance with paragraph (G)(5) of this rule. For certified pharmacy technicians, positive identification shall be documented in accordance with rule 4729:3-3-04 of the Administrative Code.

(B) A prescription copy may be transferred electronically between pharmacies if the pharmacies are accessing the same prescription records in a centralized database or the pharmacies' computers are linked in any other manner. The computer systems must be able to comply with the requirements of paragraphs (A)(4) and (A)(5)(d) of this rule. This shall include invalidation of the prescription record in the system to prevent further dispensing at the original pharmacy and, if a controlled substance prescription, the canceling of the original written prescription as required in paragraphs (A)(5)(a) and (A)(5)(b) of this rule.

(C) A prescription copy may be transferred by the use of a facsimile machine. A facsimile shall be considered a copy of the prescription if it meets the requirements of paragraph (A) of this rule, including invalidation of the original prescription. Facsimile copies must be recorded in writing pursuant to section 4729.37 of the Revised Code or stored in such a manner that will allow retention of the prescription record for three years from the date of the last transaction.

(D) Information on a prescription is the property of the patient and is intended to authorize the dispensing of a specific amount of medication for use by the patient.

(1) If the pharmacy is not able to provide the medication when needed by the patient pursuant to an authorized refill, the pharmacy shall, upon the request of the patient or patient's caregiver, transfer the prescription information to a pharmacy designated by the patient.

(2) Unless otherwise prohibited by law, no pharmacy shall refuse to transfer information about a prescription to another pharmacy when requested by the patient or patient's caregiver. Prescription information shall be transferred in accordance with this rule as soon as possible to ensure that the patient's drug therapy is not interrupted.

(3) A prescription may only be transferred upon the request or consent of the patient or patient's caregiver.

(E) Prescriptions entered into a computer system but not dispensed shall be transferred to another pharmacy, at the request of the patient or patient's caregiver, if all of the following conditions are met:

(1) The complete prescription information has been entered into the computer system.

(2) The information is displayed on the patient's profile.

(3) There is positive identification of the individual responsible for entering the prescription information into the system and the pharmacist responsible for verification of the information entered into the system.

(4) The original prescription is filed in accordance with rule 4729:5-5-03 of the Administrative Code.

(5) The prescription is assigned a prescription number.

(6) All requirements of this rule are met for the transfer of the prescription.

(7) The transfer is conducted in accordance with all state and federal laws, rules and regulations.

(8) A pharmacist may transfer an unfilled electronic prescription for a controlled substance to another pharmacist in accordance regulations or policies adopted by the United States drug enforcement administration.

(F) Transfer of prescription information between two pharmacies which are accessing the same real time, online database pursuant to the operation of a licensed central fill pharmacy shall not be considered a prescription copy and, therefore, is not subject to the requirements of this rule.

(G) A licensed pharmacy intern may send or receive copies of prescriptions in accordance with the following:

(1) The pharmacist on duty who is supervising the activity of the intern determines if the intern is competent to send or receive a prescription copy.

(2) The pharmacist on duty who is supervising the activity of the intern is responsible for the accuracy of a prescription copy that is sent or received by an intern.

(3) The pharmacist on duty must be immediately available to answer questions or discuss the prescription copy that is sent or received by an intern.

(4) The pharmacist or intern receiving a prescription copy from an intern must document the full names of the sending intern and the intern's supervising pharmacist.

(5) The intern receiving a prescription copy shall immediately transcribe the prescription and shall review the prescription with the pharmacist on duty. Prior to dispensing, positive identification of the intern and the supervising pharmacist on duty shall be recorded to identify who is responsible for the receipt of the copy.

(6) The pharmacist or intern sending a prescription copy to an intern must document the full names of the receiving intern and the pharmacist on duty.

(7) The intern shall not send or receive a prescription copy for a controlled substance.

(8) The intern and the pharmacist on duty shall comply with all the requirements of this rule.

Last updated June 11, 2026 at 11:14 AM

History

Effective: December 1, 2020
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-3-02 Therapeutic diabetic shoes.

(A) Pursuant to section 4779.02 of the Revised Code, a pharmacy intern, acting under the direct supervision of a pharmacist, may fit and measure individuals for therapeutic diabetic shoes and shoe inserts and may dispense those shoes and shoe inserts.

(B) A pharmacy intern, acting under the direct supervision of a pharmacist, shall not provide any other services that are authorized under Chapter 4779. of the Revised Code.

Last updated July 1, 2024 at 5:19 PM

History

Effective: July 1, 2024
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-3-03 Immunization administration by pharmacy interns.

(A) Pharmacy interns working under the direct supervision of a pharmacist may administer immunizations listed in paragraph (C) of this rule if an intern complies with the following:

(1) Successfully completes a course in the administration of immunizations that meets the requirements set forth in rule 4729:1-3-02 of the Administrative Code.

(2) Practices in accordance with a definitive set of treatment guidelines specified in a protocol established by a prescriber that complies with the requirements of rule 4729:1-3-02 of the Administrative Code.

(3) Receives and maintains certification to perform basic life-support procedures by successfully completing a basic life-support training course certified by the American red cross, American heart association, American safety and health institute, or other training course approved by the board. Certification shall be obtained and maintained through courses that are conducted in-person or, at a minimum, offer an in-person or electronic hands-on training component.

(4) The supervising pharmacist has completed all of the training necessary to administer immunizations in accordance with rule 4729:1-3-02 of the Administrative Code.

(B) Failure to adhere to the standard of care for administration of an immunization shall be considered a violation of this rule and may subject a pharmacy intern to discipline in accordance with rule 4729:2-4-01 of the Administrative Code.

(C) A pharmacy intern working under the direct supervision of a pharmacist may administer the same immunizations authorized for pharmacist administration as authorized by section 4729.41 of the Revised Code and rule 4729:1-3-02 of the Administrative Code.

(D) A pharmacy intern shall obtain informed consent pursuant to rule 4729:5-5-04 of the Administrative Code to administer an immunization.

(E) A pharmacy intern shall comply with the vaccine information statement requirements of the National Vaccine Childhood Injury Act, 42 USC Section 300aa-26 (12/14/1993).

(F) For each immunization administered to an individual by a pharmacy intern, other than an immunization for influenza administered to an individual eighteen years of age or older, the pharmacy intern shall notify the individual's primary care provider or, if the individual has no primary care provider, the board of health of the health district in which the individual resides or the authority having the duties of a board of health for that district under section 3709.05 of the Revised Code. The notice shall be given not later than thirty days after the immunization is administered. Notification shall be conducted using one of the following methods that is capable of confirming delivery of the required notification:

(1) Electronic mail;

(2) Interoperable electronic medical records system;

(3) Facsimile;

(4) Electronic prescribing system;

(5) Electronic pharmacy record system;

(6) Documented verbal communication;

(7) Reporting to the state's immunization registry; or

(8) Any other method of notification that might reasonably be expected to allow for the confirmed transmission of the required notification.

(G) For each immunization administered by a pharmacy intern to an individual who is younger than eighteen years of age, the pharmacy intern shall inform the individual's parent or legal guardian of the importance of well child visits with a pediatrician or other primary care provider and shall refer patients when appropriate.

(H) A pharmacy intern shall maintain the following records on file at the location(s) where the pharmacy intern administers immunizations in accordance with this rule:

(1) Proof of successful completion of a training course specified in paragraph (A)(1) of this rule; and

(2) Proof of maintenance of certification to perform basic life-support procedures in accordance with paragraph (A)(3) of this rule.

Last updated May 19, 2025 at 8:00 AM

History

Effective: May 19, 2025
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-4-01

(A) As used in this rule:

(1) "Dishonesty" means any action by a licensee, registrant or applicant to include, but is not limited to, making any statement that deceives, misrepresents or misleads, or be a party to or an accessory to any fraudulent or deceitful practice or transaction in the practice of pharmacy or in the operation or conduct of a pharmacy.

(2) "Unprofessional conduct" has the same meaning as defined in division (C) of section 4729.16 of the Revised Code and shall also include conduct that is detrimental to the best interests of the public, including conduct that endangers the health, safety or welfare of a patient or client. Such conduct shall include, but not be limited to, the following acts: coercion, intimidation, harassment, sexual harassment, improper use of private health information, threats, degradation of character, indecent or obscene conduct, and theft.

(3) "Reckless behavior" means a person who acts recklessly or who is reckless. A person acts recklessly when, with heedless indifference to the consequences, the person disregards a substantial and unjustifiable risk that the person's conduct is likely to cause a certain result or is likely to be of a certain nature. A person is reckless with respect to circumstances when, with heedless indifference to the consequences, the person disregards a substantial and unjustifiable risk that such circumstances are likely to exist.

(B)

(1) The state board of pharmacy, after notice and hearing in accordance with Chapter 119. of the Revised Code, may impose any one or more of the following sanctions on a pharmacy intern or applicant for a pharmacy intern license if the board finds the individual engaged in any of the conduct set forth in paragraph (B)(2) of this rule:

(a) Revoke, suspend, restrict, limit, or refuse to grant or renew a license;

(b) Reprimand or place the license holder on probation;

(c) Impose a monetary penalty or forfeiture not to exceed in severity any fine designated under the Revised Code for a similar offense, or in the case of a violation of a section of the Revised Code that does not bear a penalty, a monetary penalty or forfeiture of not more than five hundred dollars.

(2) The board may impose the sanctions listed in paragraph (B)(1) of this rule if the board finds a pharmacy intern or applicant for a pharmacy intern license:

(a) Has a criminal conviction for, judicial finding of guilt of, or plea of guilty to a disqualifying offense.

(b) Engaged in dishonesty or unprofessional conduct in the practice of pharmacy.

(c) Is addicted to or abusing alcohol or drugs or is impaired physically or mentally to such a degree as to render the pharmacy intern unfit to practice pharmacy.

(d) Except as provided for in paragraph (B)(2)(p) of this rule, violated, conspired to violate, attempted to violate, or aided and abetted the violation of any of the provisions of Chapter 4729. of the Revised Code, sections 3715.52 to 3715.72 of the Revised Code, Chapter 2925., 3796., 3719. or 4752. of the Revised Code, or any rule adopted by the board under those provisions.

(e) Knowingly lent the pharmacy intern's name to an illegal practitioner of pharmacy or had a professional connection with an illegal practitioner of pharmacy.

(f) Divided or agreed to divide remuneration made in the practice of pharmacy with any other individual, including, but not limited to, any licensed health professional authorized to prescribe drugs or any owner, manager, or employee of a health care facility, residential care facility, or nursing home.

(g) Committed fraud, misrepresentation, or deception in applying for or securing a license issued by the board under this chapter or under Chapter 3796., 3715., 3719. or 4752. of the Revised Code.

(h) Failed to comply with an order of the board or a settlement agreement.

(i) Violated any state or federal law, regulation or rule regardless of the jurisdiction in which the acts were committed, except for minor traffic violations such as parking violations, speeding tickets and violations such as failure to obey a red light, failure to use a turn signal or expired vehicle registration.

(j) Has been disciplined by the state board of pharmacy pursuant to section 4729.16 of the Revised Code.

(k) Has been the subject of any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction:

(i) A disciplinary action that resulted in the suspension, probation, surrender or revocation of the person's license or registration.

(ii) A disciplinary action that was based, in whole or in part, on the person's inappropriate prescribing, dispensing, diverting, administering, storing, securing, personally furnishing, compounding, supplying or selling a controlled substance or other dangerous drug.

(l) Failed to conform to prevailing standards of care of similar pharmacy interns under the same or similar circumstances, whether or not actual injury to a patient is established.

(m) Has been subject to any of the following:

(i) A finding by a court of the person's eligibility for intervention in lieu of conviction; or

(ii) A finding by a court of the person's eligibility for treatment or intervention in lieu of conviction in another jurisdiction.

(n) Has been granted entry into a diversion program, deferred prosecution program, or the equivalent thereof.

(o) Cannot practice according to acceptable and prevailing standards of care by reason of mental illness or physical illness, including, but not limited to, physical deterioration that adversely affects cognitive, motor, or perceptive skills.

(p) Is responsible for any of the following but only as a result of reckless behavior:

(i) An error in dispensing as defined in rule 4729:5-3-22 of the Administrative Code;

(ii) A product quality issue for any compounded drug preparation as defined in rule 4729:7-2-03 of the Administrative Code.

Last updated March 4, 2025 at 7:59 AM

History

Effective: March 1, 2025
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-3-04 Dispensing of naloxone by pharmacy interns.

(A) A pharmacy intern under the direct supervision of a pharmacist may dispense naloxone without a prescription to either of the following in accordance with an approved protocol specified in paragraph (B) of rule 4729:1-3-04 of the Administrative Code:

(1) An individual who there is reason to believe is experiencing or at risk of experiencing an opioid-related overdose;

(2) A family member, friend, or other person in a position to assist an individual who there is reason to believe is at risk of experiencing an opioid-related overdose.

(B) A pharmacy intern under the direct supervision of a pharmacist who dispenses naloxone pursuant to this rule shall instruct the individual to whom naloxone is dispensed verbally or in writing to summon emergency services as soon as practicable either before or after administering naloxone.

(C) Except as provided in paragraph (D) this rule, a pharmacy intern shall provide in-person training, unless the in-person requirement is waived by the board, and written educational materials to the individual to whom naloxone is dispensed that includes all the following:

(1) Risk factors of opioid overdose;

(2) Strategies to prevent opioid overdose;

(3) Signs of opioid overdose;

(4) Steps in responding to an overdose;

(5) Information on the naloxone dispensed;

(6) Procedures for administering the naloxone dispensed;

(7) Proper storage and expiration of the naloxone dispensed; and

(8) Information on where to obtain a referral for substance abuse treatment.

(D) Patient training as required by paragraph (C) of this rule is not required if the patient has previously received training and all the following apply:

(1) The patient is offered training and refuses;

(2) The pharmacy intern has documentation confirming training pursuant to this rule has been provided within the previous twelve months;

(3) A pharmacy intern under the direct supervision of a pharmacist who dispenses naloxone pursuant to this rule shall still instruct the individual to whom naloxone is dispensed verbally or in writing to summon emergency services as soon as practicable either before or after administering naloxone.

(E) A terminal distributor of dangerous drugs shall ensure that all pharmacy interns that dispense naloxone pursuant to this rule are trained on the use of naloxone and can meet the training requirements listed in paragraphs (B) and (C) of this rule.

Last updated March 23, 2026 at 1:49 PM

History

Effective: December 1, 2020
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-3-05 Pharmacy intern administration of diagnostic tests.

(A) A pharmacy intern under the direct supervision of a pharmacist may administer clinical laboratory improvement amendments (CLIA) waived diagnostic laboratory testing provided the following conditions are met:

(1) The pharmacy or facility licensed as a terminal distributor of dangerous drugs is certified by the United States department of health and human services (HHS), as a clinical laboratory through the CLIA;

(2) The pharmacy or facility licensed as a terminal distributor of dangerous drugs has obtained a CLIA certificate of waiver from HHS; and

(3) The responsible person of the terminal distributor of dangerous drugs and the terminal distributor of dangerous drugs shall ensure and document that all pharmacy interns conducting CLIA waived tests pursuant to this rule receive appropriate training to conduct testing in a safe and effective manner.

(B) A pharmacy intern under the direct supervision of a pharmacist may evaluate the results of a test administered under this rule when advising a patient or a health care professional treating a patient if the test relates to the patient's drug therapy.

(C) This rule applies only to the administration and evaluation of laboratory testing by individuals licensed or registered in accordance with Chapter 4729. of the Revised Code.

Last updated October 22, 2025 at 11:13 AM

History

Effective: January 1, 2020
Promulgated Under: 119.03

Ohio Adm.Code 4729:2-3-06 Dispensing of epinephrine autoinjectors by pharmacy interns.

(A) A pharmacy intern under the direct supervision of a pharmacist may dispense epinephrine autoinjector without a prescription to either of the following in accordance with an approved protocol specified in paragraph (B) of rule 4729:1-3-06 of the Administrative Code:

(1) An individual who there is reason to believe is experiencing or at risk of experiencing anaphylaxis if the pharmacy affiliated with the pharmacist has a record of previously dispensing epinephrine to the individual in accordance with a prescription issued by a licensed health professional authorized to prescribe drugs;

(2) An individual acting on behalf of a qualified entity, as defined in section 3728.01 of the Revised Code.

(B)

(1) A pharmacy intern under the direct supervision of a pharmacist who dispenses an epinephrine autoinjector pursuant to this rule shall instruct the individual to whom the epinephrine autoinjector is dispensed, either verbally or in writing, to summon emergency services as soon as practicable either before or after administering epinephrine.

(2) A pharmacy intern who dispenses an epinephrine autoinjector to an individual identified in paragraph (A) of this rule shall provide notification of the dispensing to the individual's primary care provider, if known, or to the prescriber who issued the individual the initial prescription for an epinephrine autoinjector. Notification shall be conducted using one of the following methods that is capable of confirming delivery of the required notification:

(a) Electronic mail;

(b) Interoperable electronic medical records system;

(d) Electronic prescribing system;

(e) Electronic pharmacy record system;

(f) Documented verbal communication;

(g) Any other method of notification that might reasonably be expected to allow for the confirmed transmission of the required notification.

(C) When a pharmacy intern dispenses an epinephrine autoinjector pursuant to this rule, the pharmacy intern shall provide to the person receiving the device instruction on the proper method of administering epinephrine with the device.

(D) A terminal distributor of dangerous drugs shall ensure that all pharmacy interns that dispense epinephrine autoinjectors pursuant to this rule are trained on the use of epinephrine and can meet the training requirements listed in paragraphs (B) and (C) of this rule.

(E) This rule does not affect the authority of a pharmacy intern to contact a prescriber to obtain a new oral prescription for an epinephrine autoinjector in accordance with the applicable provisions of division 4729:5 of the Administrative Code.

Last updated March 4, 2026 at 1:32 PM

History

Effective: January 18, 2020
Promulgated Under: 119.03

Chapter 4729:2-4 Disciplinary Actions

Ohio Adm.Code 4729:2-4-01 Disciplinary actions.